{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:12:58Z","timestamp":1782526378944,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s10147-009-0006-4","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T03:07:14Z","timestamp":1263870434000},"page":"109-111","source":"Crossref","is-referenced-by-count":2,"title":["Advanced carcinoma of the prostatic urethra in a patient with marked response to chemotherapy, leading to preservation of the bladder"],"prefix":"10.1007","volume":"15","author":[{"given":"Tsutomu","family":"Hamasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"6_CR1","unstructured":"Grignon DJ (2004) Urothelial carcinoma. In: WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs. IARC, Lyon, pp 202\u2013204"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00000478-200106000-00012","volume":"25","author":"BR Oliai","year":"2001","unstructured":"Oliai BR, Kahane H, Epstein JI (2001) Clinicopathologic analysis of urothelial carcinomas diagnosed on prostate needle biopsy. Am J Surg Pathol 25:794\u2013801","journal-title":"Am J Surg Pathol"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0090-4295(96)00253-1","volume":"48","author":"Y Senga","year":"1996","unstructured":"Senga Y, Kimura G, Hattori T et al (1996) Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer. Urology 48:703\u2013710","journal-title":"Urology"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/ajcp\/40.2.183","volume":"40","author":"N Ende","year":"1963","unstructured":"Ende N, Woods LP, Shelley HS (1963) Carcinoma originating in ducts surrounding the prostatic urethra. Am J Clin Pathol 40:183\u2013189","journal-title":"Am J Clin Pathol"},{"key":"6_CR5","first-page":"157","volume":"16","author":"Y Mori","year":"1970","unstructured":"Mori Y, Nakamura M, Ito S (1970) Transitional cell carcinoma of the prostate: report of two cases. Acta Urol Jpn 16:157\u2013161","journal-title":"Acta Urol Jpn"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1464-410X.1979.tb03605.x","volume":"51","author":"D Kirk","year":"1979","unstructured":"Kirk D, Hinton CE, Shaldon C (1979) Transitional cell carcinoma of the prostate. Br J Urol 51:575\u2013578","journal-title":"Br J Urol"},{"key":"6_CR7","volume-title":"TNM supplement: a commentary on uniform use","author":"CH Witekind","year":"2001","unstructured":"Witekind CH, Henson DE, Hutter RVP et al (2001) TNM supplement: a commentary on uniform use, 2nd edn. Wiley, New York","edition":"2"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(17)60451-8","volume":"109","author":"RK Rhamy","year":"1973","unstructured":"Rhamy RK, Buchanan RD, Spalding MJ (1973) Intraductal carcinoma of the prostate gland. J Urol 109:457\u2013460","journal-title":"J Urol"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0090-4295(84)90098-0","volume":"24","author":"GS Nicolaisen","year":"1984","unstructured":"Nicolaisen GS, Williams RD (1984) Primary transitional cell carcinoma of prostate. Urology 24:544\u2013549","journal-title":"Urology"},{"key":"6_CR10","first-page":"495","volume":"46","author":"M Uemura","year":"2000","unstructured":"Uemura M, Imamura R, Inoue H et al (2000) Primary transitional call carcinoma of prostate: a case report. Acta Urol Jpn 46:495\u2013498","journal-title":"Acta Urol Jpn"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1671::AID-CNCR22>3.0.CO;2-A","volume":"88","author":"DF Bajorin","year":"2000","unstructured":"Bajorin DF, McCaffrey JA, Dodd PM et al (2000) Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dose schedules. Cancer (Phila) 88:1671\u20131678","journal-title":"Cancer (Phila)"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(01)64473-2","volume":"158","author":"JL Pariente","year":"1997","unstructured":"Pariente JL, Bordenave L, Michel PH et al (1997) Initial evaluation of CYFRA 21\u20131 diagnostic performance as a urinary marker in bladder transitional cell carcinoma. J Urol 158:338","journal-title":"J Urol"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/01.ju.0000176742.53556.25","volume":"174","author":"C Andreadis","year":"2005","unstructured":"Andreadis C, Touloupidis S, Galaktidou G et al (2005) Serum CYFRA 21\u20131 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy. J Urol 174:1771\u20131776","journal-title":"J Urol"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urology.2006.05.059","volume":"69","author":"J Palou","year":"2007","unstructured":"Palou J, Baniel J, Klotz L et al (2007) Urothelial carcinoma of the prostate. Urology 69:50\u201361","journal-title":"Urology"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-009-0006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-009-0006-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-009-0006-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:24:50Z","timestamp":1559147090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-009-0006-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s10147-009-0006-4","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}